This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Learn how to effectively engage in virtual networking for financial planners to expand your reach and connect with industry experts.
16,067 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A nationwide recall has been issued for nearly 90,000 bottles children's ibuprofen after reports of contamination. Fa...
The latest inflation report out shows retirees still face rising essentials even as COLA gains ease. Here's what that...
A corporate insider sold a meaningful chunk of stock after a record revenue year. This article breaks down what such ...
New data on the gender wage gap show women still earn far less than men, marking a second straight year of ground los...
A Crinetics director sells 5,000 shares as the stock dips. This guide breaks down what insider moves really mean for ...
As Warren Buffett's successor, Greg Abel has begun steering Berkshire Hathaway's portfolio with careful turns. A nota...
The SpaceX IPO could unlock a new era for private-market access. This guide breaks down why SpaceX matters, how to ge...
A provocative nickname sparked online chatter and real-world worries about policy and prices. This guide explains how...
The Senate approved a resolution to withhold lawmakers' pay during any government shutdown, a bid to curb stalemates ...
A pivotal Investor Day pushed Schwab stock higher on Friday as management raised guidance on revenue growth and net i...
A Madrid court clears Shakira of a 2011 tax-year fraud claim and orders a 60 million euro refund, including interest....